Literature DB >> 34541584

Identifying Symptom Clusters Through Association Rule Mining.

Mikayla Biggs1, Carla Floricel2, Lisanne Van Dijk3, Abdallah S R Mohamed3, C David Fuller3, G Elisabeta Marai2, Xinhua Zhang2, Guadalupe Canahuate1.   

Abstract

Cancer patients experience many symptoms throughout their cancer treatment and sometimes suffer from lasting effects post-treatment. Patient-Reported Outcome (PRO) surveys provide a means for monitoring the patient's symptoms during and after treatment. Symptom cluster (SC) research seeks to understand these symptoms and their relationships to define new treatment and disease management methods to improve patient's quality of life. This paper introduces association rule mining (ARM) as a novel alternative for identifying symptom clusters. We compare the results to prior research and find that while some of the SCs are similar, ARM uncovers more nuanced relationships between symptoms such as anchor symptoms that serve as connections between interference and cancer-specific symptoms.

Entities:  

Keywords:  Association rule mining; PRO; Symptom clusters

Year:  2021        PMID: 34541584      PMCID: PMC8444285          DOI: 10.1007/978-3-030-77211-6_58

Source DB:  PubMed          Journal:  Artif Intell Med Conf Artif Intell Med (2005-)


  13 in total

Review 1.  Multivariate methods to identify cancer-related symptom clusters.

Authors:  Helen M Skerman; Patsy M Yates; Diana Battistutta
Journal:  Res Nurs Health       Date:  2009-06       Impact factor: 2.228

Review 2.  Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations.

Authors:  Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden
Journal:  J Natl Cancer Inst       Date:  2017-01-24       Impact factor: 13.506

3.  Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy.

Authors:  Andrew Wentzel; Peter Hanula; Lisanne V van Dijk; Baher Elgohari; Abdallah S R Mohamed; Carlos E Cardenas; Clifton D Fuller; David M Vock; Guadalupe Canahuate; G E Marai
Journal:  Radiother Oncol       Date:  2020-05-16       Impact factor: 6.280

Review 4.  Cancer symptom clusters: clinical and research methodology.

Authors:  Jordanka Kirkova; Aynur Aktas; Declan Walsh; Mellar P Davis
Journal:  J Palliat Med       Date:  2011-08-23       Impact factor: 2.947

5.  Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.

Authors:  David I Rosenthal; Tito R Mendoza; Clifton D Fuller; Katherine A Hutcheson; X Shelley Wang; Ehab Y Hanna; Charles Lu; Adam S Garden; William H Morrison; Charles S Cleeland; G Brandon Gunn
Journal:  Cancer       Date:  2014-04-07       Impact factor: 6.860

6.  Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

Authors:  David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K Kian Ang; Xin S Wang; Charles S Cleeland
Journal:  Head Neck       Date:  2007-10       Impact factor: 3.147

7.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

8.  Precision Risk Analysis of Cancer Therapy with Interactive Nomograms and Survival Plots.

Authors:  G Elisabeta Marai; Chihua Ma; Andrew Thomas Burks; Filippo Pellolio; Guadalupe Canahuate; David M Vock; Abdallah S R Mohamed; Clifton David Fuller
Journal:  IEEE Trans Vis Comput Graph       Date:  2018-03-20       Impact factor: 4.579

9.  Conditional Survival Analysis of Patients With Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram.

Authors: 
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.